Abstract
Tau microtubule-associated proteins, encoded by the MAPT gene, are mainly expressed in neurons participating in axonal transport and synaptic plasticity. Six major isoforms differentially expressed during cell development and differentiation are translated by alternative splicing of MAPT transcripts. Alterations in the expression of human Tau isoforms and their aggregation have been linked to several neurodegenerative diseases called tauopathies, including Alzheimer’s disease, progressive supranuclear palsy, Pick’s disease, and frontotemporal dementia with parkinsonism linked to chromosome 17. Great efforts have been dedicated in recent years to shed light on the complex regulatory mechanism of Tau splicing, with a perspective to developing new RNA-based therapies. This review summarizes the most recent contributions to the knowledge of Tau isoform expression and experimental models, highlighting the role of cis-elements and ribonucleoproteins that regulate the alternative splicing of Tau exons.
Funder
Italian Ministry of Research and University
University of Verona
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference157 articles.
1. Tau in Physiology and Pathology;Wang;Nat. Rev. Neurosci.,2016
2. Tau and Tauopathies;Arendt;Brain Res. Bull.,2016
3. Cellular and Pathological Heterogeneity of Primary Tauopathies;Chung;Mol. Neurodegener.,2021
4. MAPT Mutations, Tauopathy, and Mechanisms of Neurodegeneration;Strang;Lab. Investig.,2019
5. Predictive and Prognostic Value of the TauProtein in Breast Cancer;Bonneau;Anticancer Res.,2015
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献